Processing .....please wait.. 
The article has been forwarded.... 
Morepen files patent for cholesterol drug in U.S, Canada
By siliconindia staff writer
|
Wednesday, 02 February 2005, 20:30 IST
NEW DELHI: The City based Dr. Morepen Laboratories Ltd has filed patent for a 10 billion dollar cholesterol-lowering drug -- Atorvastatin Calcium in U.S and Canada.
''Morepen is in the process of finalizing tie-ups with US generic companies for launch of the product and aims at capturing 15-20 per cent market share in post-patent regime,'' the pharma firm said.
The market size of Atovarstatin Calcium worldwide is estimated to be about $10 billion.
The company said it had got approval for the drug under the Patent Cooperation Treaty (PCT) last year and the same was published by World Intellectual Property Organisation.
Besides the US and Canada, Morepen has also filed the manufacture highly pure and stable crystalline polymorphic ''Form VI'' and amorphous forms of Atorvastatin.patent in the European nations among 33 countries. Morepen has the proprietary technology to